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Pathways through which glucose induces a rise in [Ca2]i of polymor-
phonuclear leukocytes of rats. Basal levels of [Ca2}i arc elevated in
diabetes mellitus. Such an abnormality is most likely due to both increased
calcium influx into cells and decreased efflux of this ion out of the cells.
The present study examined the cellular pathways that are responsible for
hyperglycemia-induced acute rise in polymorphonuclear leukocytes
(PMNL), and explored whether such a rise is due to increased calcium
entry into PMNL and/or to calcium release from their intracellular stores.
There were dose dependent and time dependent rises in the [Ca21i of
PMNL exposed to high concentrations of glucose. Similar effects were
observed when the PMNL were exposed to high concentrations of choline
chloride or mannitol. A substantial part of the risc in [Ca2]i was inhibited
when the media contained verapamil or nifedipine or when the PMNL
were placed in calcium free media, and the rise in [Ca21i was completely
abolished when the PMNL were placed in calcium free media containing
ryanodine. GDPI3S or pertussis toxin almost completely prevented the
glucose-induced rise in [Ca21i of PMNL. Rp-cAMP, H-89 or staurospor-
inc produced significant inhibition of the rise in [Ca2]i. High concentra-
tions of glucose produced a dose dependent shrinkage of PMNL volume
over a period of two hours. The volume of PMNL, however, was normal
after 24 hours in in vitro incubation studies as well as after 1,2 and 12 days
of streptozotocin-induced hyperglycemia in rats. The results are consistent
with the formulation that the Osmotic activity (cell shrinkage) of the high
glucose concentrations activates G protein(s) which then stimulates the
adenylate-cAMP-protein kinase A pathway, phospholipase C system and
calcium channels. The stimulation of these cellular pathways permits both
calcium influx into the PMNL as well as mobilization of calcium from their
intracellular stores. Both of these events contribute to the acute rise in
their [Ca21i. It is possible that the rise in [Ca2Ii is critical for the
stimulation of the events that lead to the generation and accumulation of
inorganic osmolytes to restore cell volume to normal.
Studies in patients with diabetes mellitus and in animals with
experimental diabetes showed that the basal levels of cytosolic
calcium ([Ca2Ji) of many cells are elevated 11—91. A rise in the
basal levels of [Ca2 ]i is usually due to a combination of increased
calcium influx into cells and a decreased calcium efflux out of cells.
Indeed, these abnormalities were encountered in chronic renal
failure [101 and in phosphate depletion [11], conditions that are
associated with elevated basal levels of [Ca2 ji in many cells.
It is plausible, therefore, to assume that both augmented
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calcium entry into cells and decreased calcium exit out of them are
present in diabetes mellitus. Variable data have been reported in
this regard. Certain studies support the notion that high glucose
concentration induces an acute rise in [Ca2]i of insulinoma cells
[121, pancreatic islets [131, normal human red blood cells [14J and
cultured rat tail artery vascular smooth muscle cells [151. Others,
however, reported that glucose has no effect on [Ca2]i of isolated
fat cells [161, and Williams and Schrier [171 found that elevated
extracellular glucose concentration depressed basal and voltage
sensitive activated (Bay K 8633, iO M) calcium uptake by
cultured rat vascular smooth muscle cells. Also, impairment in the
function of the pumps that are involved in the exit of calcium out
of the cells either directly (Ca2ATPase) or indirectly (Na-
K1ATPa5e) have been observed in diabetes [18—24], but an
increase or no change in the activities of these pumps have also
been reported [25—28].
The mechanisms responsible for the potential derangements in
calcium influx into and/or efflux out of cells in diabetes are not
well understood. We have recently reported that the basal levels
of [Ca2]i are elevated in polymorphonuclear leukocytes (PMNL)
from patients with type II diabetes mellitus [9]. Therefore, these
cells are useful for the evaluation of the mechanisms leading to a
rise in [Ca2]i in diabetes. The present study examined the
cellular pathways that are activated by hyperglycemia leading to
an acute rise in [Ca24 ]i of PMNL from normal rats and evaluated
whether such an acute rise in [Ca2}i is due to calcium influx into
PMNL and/or to the release of calcum from their intracellular
stores.
Methods
Normal Sprague-Dawley rats weighing 285 to 310 (mean 298
0.4) g were used. On the day of the experiment, the rats were put
under light anesthesia, and blood was drawn directly from the
heart under sterile conditions. The blood was placed into sterile
test tubes containing 100 U of preservative free heparin (Gibco
Laboratories, Grand Island, NY, USA) per 1 ml of blood. PMNL
were isolated from the whole blood according to the method
described by Ferrante and Thong [291 with modification. A total
of 3.0 ml of fresh heparinized blood was placed over two layers of
Ficoll-Hypaque solution in 15 ml conical polypropylene tubes.
The bottom layer was made of 3 ml Mono-Poly Resolving
Medium with density of 1.114 g/ml (Flow Laboratories, Inc.,
McLean, VA, USA) and a second layer of 1.0 ml of Isolymph with
density of 1.077 g/ml (Gallard-Schlesinger Industries, Inc., Cane
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Place, NY, USA). The tubes were centrifuged at 1270 X g for 45
minutes at room temperature. This procedure resulted in the
separation of mononuclear and polymorphonuclear cells into two
distinct bands with the red blood cell pellet at the bottom of the
tube. The PMNL were aspirated with a Pasteur pipette and
washed twice in Hank's balanced salt solution (HBSS). Cells from
two animals were pooled for each study. Cell purity, as deter-
mined by Wright's staining, was greater than 97% and cell viability
assayed by the Trypan blue exclusion method exceeded 98%.
Difficulty in the separation of PMNL was encountered in few
blood specimens and this was overcome by extending the time of
centrifugation.
Resting levels of [Ca24]i of the PMNL were estimated with
Fura 2-AM (Sigma Chemical Co., St. Louis, MO, USA). A sample
of 5 X 106 PM NI. was washed with solution I containing (in mM):
NaCI, 132; KCI, 3; MgSO4 1; NaH2PO4, 1.2; D-glucose, 10;
HEPES, 10; CaCl2, 0.02 (pH was adjusted to 7.4 with Tris buffer),
and spun at 300 X g for 15 minutes. The pellet was resuspended
in 490 .d of the above solution and 10 ,il of Fura 2-AM dissolved
in DMSO giving a final concentration of 4 jtM of Fura 2-AM. The
mixture was then incubated in water bath at 37°C for 30 minutes.
After this incubation, the cells were washed and resuspended in
solution I. Measurements of [Ca2Ii were done with Perkins
Elmer fluorescence spectrophotometer Model LS 5B (Perkin
Elmer, CT, USA) at excitation wavelength of 340 nm and 380 nm
and emission wavelength of 510 nm with a slit of 10 and 20 mm,
respectively. An aliquot of 100 1 of PMNL suspension was added
to a spectrophotometer euvette containing 1.9 ml of solution TI,
which was the same as solution I except for its CaCI2 concentra-
tion being 1 mvi. Autofluorescence from cells and/or added
reagents was monitored during each experiment and was not
found to be a significant factor. Maximal fluorescence (Fmax) and
minimal fluorescence (F,,1) were measured with 0.05% Triton
and 5 mrvt EGTA in Tris base buffer (pH 8.0), respectively.
Calculation of [Ca2]i was done using the Grynkiewicz, Poenie
and Tsien equation [301, and the dissociation constant for Ca2 -
Fura 2 was assumed to be 225 flM.
In order to measure the volume of PMNL, an aliquot of 50 id
of PMNL suspension was added to 9.950 ml of isotone (Curtin
Matheson, Yorba Linda, CA, USA), and the mixture was aspi-
rated through a 100-j.Lm operation tube into the Coulter chan-
nelyzer model C1000 (Coulter Electronics, Hialeah, FL, USA).
The average cell volume was calculated from the volume distri-
bution curve. Cell volume was measured after incubation of
PMNL for 1, 5, 10 and 60 minutes in medium containing 10, 20
and 30 m glucose. Studies were also done with media containing
30 m choline chloride. In addition volume of PMNL was
determined after incubation of the cells for 2 and 24 hours in
media containing 5.5 or 30 m glucose. Diabetes was produced by
intraperitoneal injection of 50 mg of streptozotoein/kg body wt.
The volume of PMNL obtained from rats after 1, 2 and 12 days of
the injection of streptozotocin was measured. Statistical analysis
was done using a paired and unpaired t-test and data are
presented as mean 1 SE.
Results
Figure 1 depicts the levels of [Ca2 Ji of PMNL after their
incubation in a medium containing 30 m glucose. Within five
minutes, the [Ca2Ii increased significantly (P < 0.05) from 96
1.() nM to 102 1.2 n, with the values increasing with time
reaching 122 0.7 nM (P < 0.01 vs. baseline level) after one hour.
The levels of [Ca2]i of PMNL after their incubation for one hour
with various concentrations of glucose are given in Figure 2.
There was a dose dependent increase in [Ca2]i of the PMNL.
To determine whether the effect of hyperglycemia was due to
glucose, per se, or to its osmotic action, we examined the effect of
choline chloride or mannitol added to the 5.5 m glucose medium
to generate similar osmotic effect to that produced by a higher
concentration of glucose. Choline chloride or mannitol produced
quantitatively similar effect on [Ca2]i of PMNL as glucose (Fig.
2). On the other hand, a medium containing 5.5 m glucose and
adequate urea to generate 30 mOsm did not alter [Ca2]i of
PMNL; the levels of [Ca2}i of PMNL incubated for one hour in
media containing 5.5 m glucose were 93 1.9 m, and those of
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Fig. 1. The [Ca2 Ji of PMNL incubated for various time periods in medium
containing 30 mu glucose. Each datum point represents the mean 1 SF
of seven studies.
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Fig. 2. Relationship between /Ca2 'ii of PMNL and various concentrations
of glucose (0), of choline chloride (•) or mannitol (LII) in media. Each
datum point represents the mean 1 se of 11 to 19 studies.
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Fig. 3. Effect of 30 mi glucose on the I Ca2 Ji of PMNL when they were
incubated for one hour in a calcium containing (U) and calcium free ()
media. The magnitude of the increment in [Ca2Ji of PMNL placed in a
calcium containing medium was signifIcantly (P < 0.01) greater than that
observed with a calcium free medium at 15, 30 and 60 minutes. Each
column represents the mean of 6 to 7 studies and brackets denote I SE.
PMNL incubated for one hour in the urea containing media were
96 3.1 mM.
The next step was to examine whether the rise in [Ca2]i of
PMNL induced by glucose was due to calcium influx into the
PMNL. Figure 3 shows the changes in [Ca2]i of PMNL after
their incubation for various periods of time in media containing 30
m glucose and 1 mtvt CaCI2 or no calcium. The medium with no
calcium contained 100 /SM of EGTA. The [Ca2]i of PMNL
incubated in both media increased significantly (P < 0.01), but the
increments were significantly (P < 0.01) greater when the PMNL
were placed in a calcium containing medium for 15, 30 and 60
minutes. The increment in the absence of calcium in the medium
was 57 4.3% of that observed in the presence of calcium in the
medium. These observations indicate that only part of the glu-
cose-induced rise in [Ca2]i is due to calcium influx from the
medium into the cells, and about 43 5.5% of the rise in [Ca2]i
is due to mobilization of intracellular calcium store.
If the glucose-induced rise in [Ca2ji in PMNL is due in part to
calcium influx, calcium channel blockers should totally or partially
inhibit this effect of glucose if the latter activates calcium channels
inhibitable by these compounds. To examine this issue, we
incubated PMNL for one hour in media containing 5.5 ms
glucose, 5.5 m glucose with 40 jrM verapamil or 4 /.tM nifedipine,
30 m glucose, or 30 m glucose with 40 j.rM verapamil or 4 jIM
nifedipine. Similar studies were done where the PMNL were
placed in media containing 5.5 m glucose and choline chloride
generating 30 mOsm/kg/H20. The results of these studies show
that both verapamil and nifedipine produced significant (P <
0.01) inhibition of the glucose or choline chloride-induced rise in
[Ca2]i (Fig. 4). The inhibition by verapamil of the glucose-
induced rise in [Ca2]i was 46 5.2% and by nifedipine was 55
2.9%. The inhibition by verapamil of choline chloride-induced rise
in [Ca2]i was 49 3.7% and by nifedipine was 63 5.6%. The
magnitudes of these inhibitory effects were not different from the
component of the rise in [Ca2]i due to calcium influx into PMNL
observed in the studies with and without calcium in the media.
These effects of verapamil and nifedipine were not due to cellular
toxicity since these agents did not affect the [Ca2]i of PMNL
0
Fig. 4. Effect of 40 pM verapamil (A) or 4 p.M nifedipine (B) on glucose or
choline induced rise in fCa2]i of PMNL. The magnitude of the rise in
[Ca21i in the presence of the calcium channel blockers was significantly
(P < 0.01) smaller than that observed with glucose or choline chloride
alone. Each column represents the mean of 6 to 7 studies and brackets
denote 1 SE. Symbols in A are: (•) glucose 30 mM; ()glucose+verapamil
40 JIM; () glucose+nifedipine 4 p.M. Symbols in B are: (•) choline 30 nM;() choline+verapamil 40 /LM; () choline+nifedipine 4 p.M.
incubated in 5.5 m glucose. The [Ca2]i levels of PMNL
incubated in the absence and presence of 40 jIM verapamil were
92 3.4 and 91 3.1 n, respectively, and in the absence or
presence of 4 JIM nifedipine were 90 5.7 and 90 6.4 nM,
respectively.
We then studied the effect of ryanodine, an agent that depletes
[31] and/or inhibits calcium release [32] from intracellular stores,
in order to examine whether mobilization of calcium from intra-
cellular stores contributes to the glucose-induced rise in [Ca2]i.
PMNL were incubated for different time periods in media con-
taining 5.5 m glucose and 1 mrvt CaCl2, and 30 mM glucose, and
1 jIM iyanodine in the presence or absence of CaCl2. The
glucose-induced rise in [Ca2]i with medium containing calcium
and ryanodine was significantly (P < 0.01) smaller than that
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Fig. 5. Changes in [Ca2 7i of PMNL incubated for various periods of time
with 30 mM glucose in the presence of calcium in the medium with ( and
without (•) iyanodine, and in medium containing 30 mz'n glucose and
tyanodine but without calcium (L). Ryanodine caused a significant (P <
0.01) decrease in the magnitude of the glucose-induced rise in [Ca2*]i.
The glucose-induced rise in [Ca2]i of PMNL placed in calcium free
medium containing ryanodine was negligible. Each column represents the
mean of 6 to 7 studies and brackets denotes 1 SE.
observed with medium containing glucose and calcium at 15, 30
and 60 minutes; there was negligible rise in [Ca2]i of PMNL
incubated in medium containing glucose and ryanodine but no
calcium (Fig. 5). Calculation of the percent of the glucose-induced
rise in [Ca2]i inhibitable by syanodine yielded a value of 54
4.4%. This value is not different from that attributable to mobi-
lization of calcium from intracellular shores calculated from
studies with calcium free media or from those with verapamil or
nifedipine.
The finding that high glucose or choline chloride mobilizes
intracellular calcium stores suggests that these agents activate
intracellular pathways. We, therefore, examined whether a (i
protein(s) was involved in this process. To this end, we evaluated
the effect of the G protein inhibitor, GDPj3S, and of pertussis
toxin, an agent that prevents receptor-mediated processes which
utilize G proteins [33]. Figure 6 depicts the effect of various doses
of GDPf3S and of pertussis toxin on the glucose or the choline
chloride-induced rise in [Ca2ji of PMNL incubated with these
agents for one hour. GDPI3S in a dose dependent manner
inhibited the rise in [Ca2]i produced by glucose or choline
chloride. At 100 ILM of GDP/3S, the rise in [Ca2]i was negligible.
Pertussis toxin exerted similar effects to that observed with
GDPI3S, in that it caused a dose dependent inhibition of the
glucose or the choline chloride-induced rise in {Ca2]i, and at a
concentration of 0,4 j.tg of pertussis toxin!dl, the effect of glucose
was almost completely abolished.
Activation of G protein(s) would stimulate the adenylate-
cyclase-cAMP pathway [33], the phospholipase C pathway [33]
and may directly activate calcium channels [34]. We, therefore,
examined the effects of agents that interfere with the adenylate
cyclase-cAMP-protein kinase A pathway. Both Rp-cAMP, a com-
petitive inhibitor of cAMP binding to the R subunit of protein
kinase A [35] and H-89, an inhibitor of protein kinase A [36]
caused a dose-dependent inhibition of the glucose or the choline
o • • I • I • I
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Fig. 6. Effect of various concentrations of GDPI3S (A,) orpertussis toxin (B)
on the glucose (0) or choline chloride (•) induced rise in [Ca2/i of PMNL
incubated with these agents for one hour. Each datum point represents the
mean of 5 to 6 studies and the brackets denote 1 SE. These agents almost
abolished most of the glucose or choline-induced rise in [Ca2]i.
chloride-induced rise in [Ca2 ]i of PMNL after their incubation
for one hour with these agents (Fig. 7).
TPA, an activator of protein kinase C, produced a significant
(P < 0.01) dose dependent rise in the [Ca2]i of PMNL incubated
for one hour in medium containing 5.5 mM glucose and 1 mM
CaCl2 (Fig. 8). Staurosporine, an inhibitor of protein kinase C
[37], caused a dose dependent inhibition of glucose or choline
chloride-induced rise in [Ca2]i of PMNL incubated for one hour
with these agents (Fig. 9). Staurosporine alone did not alter the
[Ca2]i of PMNL. When these cells were incubated in 5.5 mM
glucose in the absence of staurosporine, the levels of [Ca2]i were
88 4.4 m and in the presence of i0 and iO— staurosporine
the levels were 89 4.4 ni and 89 3.8 nM, respectively.
Verapamil (20 and 40 xM) produced a significant (P < 0.01)
inhibition of the TPA (15 15M)-induced rise in [Ca2]i (Fig. 10).
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The percent inhibition was 32 4.0 with 20 ILM verapamil and
58 3.0 with 40 iM verapamil.
The normal volume of PMNL was 161 0.9 11 (N = 34). The
volume of the PMNL remained stable during their incubation for
1, 5, 10, 60, and 120 minutes, as well for 24 hours in the media
+
c'J
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Fig. 9. Effect of various concentrations of staurosporine on the glucose or
choline chloride-induced rise in [Ca2ji of PMNL incubated for one hour
with this agent. Symbols are: •) no staurosporine; () staurosporine 1O
jsM; (111111) staurosporine 10 jLM. Each column represents mean of six
studies and brackets denote 1 SE.
containing 5.5 m glucose. After one minute of incubation in a
medium containing 10, 20, or 30 m glucose, the PMNL volume
was reduced and the magnitude of the shrinkage in volume was
directly related to the concentration of glucose in the media
[2.6 4% (N = 6), 5.1 0.3% (N = 5) and 7.6 0.6% (N = 6),
respectively]. There were no further decrements in the volume of
PMNL during the following 120 minutes (Fig. 11). Choline
chloride produced similar effects on PMNL volume. After 24
2036
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Fig. 8. Effect of various concentration of TPA on the /Ca2]i of PMNL
incubated for one hour in media containing 30 m glucose and 1 mivi CaCI
—
Each datum point represents the mean I SE of 18 studies.
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Fig. 7. Effect of two concentration of Rp cAMP (A) and H-89 (B) on the
glucose (0) or choline chloride (•)-induced rise in [Ca2 Ji. Each datum
point represents the mean 1 SE of 6 to 7 studies.
0
Glucose 30 mM
Demerdash et al: [Ca2/i, PMNL and glucose 2037
0-4
Fig. 10. Effect of 20 () and 40 (E) — verapamil on the iPA • 15
p.M -induced rise in [Ga2 '/i of PMNL incubated for one hour with these
agents. Verapamil caused a significant dose-dependent reduction in the
TPA-indueed rise in [Ca2]i of the PMNL. Each column represents mean
of seven experiments and hraekets denotes I 5E.
hours of incubation of PMNL in a medium containing 30 mvt
glucose, the volume of PMNL (161 1.6 fi, N = 5) was not
different of that of PMNL incubated for 24 hours in a medium
containing 5.5 mlvi glucose (162 3.7 fi, N = 5) nor from the
normal values. The effects of streptozotocin-induced hyperglyce-
mia on PMNL volume are given in Table 1. Despite significant
hyperglycemia for the 1, 2 and 12 days, the volume of PMNL were
not different from normal.
Discussion
The results of the present study demonstrate that glucose
causes a time-dependent and dose-dependent increase in [Ca2]i
of PMNL of rats. These observations are similar to those of
Barbagallo et al [151, who also reported time and dose interac-
tions between glucose and [Ca2 ji of cultured rat tail artery
vascular smooth muscle cells. Our data further show that the
effect of glucose is not due to a specific characteristics of glucose,
but rather due to its osmotic effect, that is, shrinkage of PMNL
volume, Indeed, two other agents, choline chloride and mannitol,
in similar molar concentrations to those of glucose produced a rise
in [Ca2Ii of PMNL almost identical to that induced by glucose,
while urea, which penetrates the cells and does not cause shrink-
age, did not induce a rise in [Ca2 ]i. These observations are
different from those of Barbagallo et al [15],who reported that 20
mM mannitol or L-glucose failed to cause a rise in [Ca2]i of
cultured rat tail artery vascular smooth muscle cells, and of
Williams and Sehrier [17] who reported that mannitol did not
mimic glucose in decreasing the [Ca24 ]i of cultured rat vascular
smooth muscle cells. The results of the studies of these two groups
are not in agreement with each other and are different from our
observations. The reason for these differences is not evident; it
may be related to the different type of cells studied, that is, smooth
vascular muscle cells versus PMNL, and/or cultured cells versus
freshly prepared cells.
An acute increase in [Ca2]i of PMNL could be due to an influx
of calcium into cells and/or mobilization of calcium from intra-
cellular stores. Various findings in our study indicate that high
concentrations of glucose cause a rise in [Ca2 ]i of PMNL both by
increasing calcium entry into these cells and by mobilization of
calcium from their intracellular stores, First, the magnitude of the
glucose-induced rise in [Ca2]i in the PMNL was significantly
(P c 0.01) greater when the cells were incubated in a calcium
containing medium than when the PMNL were placed in a
calcium free medium. Second, the calcium channel blockers,
verapamil or nifedipine, also caused a significant reduction in the
magnitude of the glucose-induced rise in [Ca2]i of the PMNL.
Third, ryanodine significantly reduced the glucose-induced rise in
[Ca2]i of the PMNL, and the elevation in [Ca2'ji was completely
abolished when the PMNL were incubated in a calcium free
media in the presence of ryanodine. Quantitative evaluation of
the results of the studies on the effect of glucose on [Ca2fli of
PMNL in the presence of calcium channel blockers and of PMNL
incubated in calcium containing and calcium free media in the
presence or absence of tyanodine indicate that about 50% of the
glucose-induced rise in [Ca24ji is due to influx of calcium into the
PMNL, and the source of the other 50% is intracellular stores. It
is of interest that the effect of choline chloride is quantitatively
and qualitatively similar to that of glucose.
Both verapamil and nifedipine, agents that block L-type cal-
cium channels [38], produced a significant inhibition of the
glucose and choline-induced rise in [Ca2]i. These observations
suggest that high glucose or choline chloride concentrations
activate L-type calcium channels. Our data show that several
pathways may be involved in the activation of such channels.
First, generation of cAMP by the stimulation of the adenylate
eyclase-eAMP system activates L-type calcium channels via
cAMP-dependent phosphorylation of these channels [39] and this
process utilizes cAMP dependent protein kinase A [40]. Our
findings that both Rp-eAMP, a competitive inhibitor of cAMP
binding to the R subunit of protein kinase A [35], and H-89, an
inhibitor of protein kinase A [36], inhibited both the glucose- and
choline chloride-induced rise in [Ca24]i in a dose dependent
manner indicate that the adenylate-eAMP-protein kinase A path-
way is involved in the glucose and choline chloride-induced
activation of L-type calcium channels of PMNL. This proposal
implies that PMNL possess L-type calcium channels that are
inhibitable by calcium channel blockers. Certain data suggest that
PMNL may not have L-type calcium channels [41]. On the other
hand, Simchowitz and Spilberg [42] showed that a 45Ca influx into
PMNL is inhibited by verapamil. Also, Alexiewiez et al [431 and
HOrl et al [1 reported that treatment of dialysis patients with
nifedipine or verapamil was followed by restoration of the ele-
vated basal levels of [Ca2 Ji of their PMNL toward normal values.
These observations and those of the present study suggest that
either L-type calcium channels do exist in PMNL or other types of
calcium channels inhibitable by verapamil or nifedipine may be
present in PMNL [45].
Second, 0 protein(s) can directly activate L-type calcium
channels [341. Our results show that the activation of G protein(s)
is involved in the processes leading to the rise in [Ca2]i of
PMNL. Therefore, it appears that stimulation of 0 protein(s) by
high glucose or choline chloride concentrations may activate the
calcium channels through the stimulation of the adenylate eyelase-
cAMP-protein kinase A system and may also directly activate the
calcium channels.
Activation by 0 protein(s) also stimulates the phospholipase C
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1 Day 13.4 0.2 162 0.6
(12.1—18.7)
2 Days 19.9 2.0 161 1.3
(10.0—33.0)
12 Days 19.0 1.5 163 3.1
(16.0—23.6)
_________________
Data are presented as mean I SE. Data in brackets provide the range.
pathway [33, 461, which leads to the generation of inositol
1,4,5-triphosphate (1P3) and diacylglycerol and to the activation
of protein kinase C. These parameters were not measured in the
present study. However, two observations in our study support the
notion that protein kinase C of the PMNL is activated during their
exposure to high concentrations of glucose or choline chloride.
First, staurosporine, an inhibitor of protein kinase C activity [37],
caused a significant inhibition of the glucose or choline chloride-
induced rise in [Ca2 ji of PLMNLs. Second, TPA, an activator of
protein kinase C, caused a dose-dependent rise in [Ca2 ']i of
PMNL. Also, others reported that hyperglycemia may increase
the activity [1 or the translocation of protein kinase C [481 or
both [49]. Activation of protein kinase C causes a rise in [Ca2]i
of many cells including thymocytes [50], pancreatic islets [51],
hepatocytes [52], adipocytes [531 and renal proximal tubule cells
[51 It is, therefore, possible that activation of protein kinase C by
glucose participates in the glucose-induced rise in [Ca2Ii of
PMNL.
The mechanisms through which activation of protein kinase C
causes a rise in [Ca2 ]i of PMNL are not evident. It has been
reported that stimulation of protein kinase C by a phorbol ester
can raise [Ca2]i by depolarization of cell membrane of insuli-
noma cells [55]. Such an action will permit calcium influx into
cells. It is also theoretically possible that protein kinase C may
stimulate L-type and/or other calcium channels. Our finding that
verapamil caused significant inhibition a TPA-induced rise in
Fig. 11. Changes in volume of PMNL incubated
with high concentrations of glucose or choline
chloride for different periods of time. Each
column represents the mean of 5 to 6
experiments and the brackets, detnote 1 SE.
Symbols are: (U) 30 mM choline chloride; (LI)
30 mvi glucose; (tIl) 20 mat glucose; ([1) 10 mM
glucose.
[Ca2]i of PMNL support the proposal that protein kinase C
activates calcium channels of PMNL.
An additional potential mechanism through which calcium
enters into PMNL during their exposure to high concentration of
glucose or choline chloride is the activation of Na-H exchanger
by cell shrinkage [56, 57]. Such a process would lead to H exit
out of PMNL with a consequent sodium accumulation in these
cells, an event that would stimulate the Na-Ca2 exchange
leading to calcium entry into PMNL.
Many cells possess stretch-activated cation channels that permit
non-selective movements of cations [58—60]. These channels may
be activated during expansion or shrinkage of cell volume. If such
channels exist in PMNL and if shrinkage of their volume during
the exposure to high concentration of glucose or choline chloride
stimulates such channels, we would expect an increase in calcium
influx into the PMNL, thus contributing to the rise in their
[Ca2]i. At present no data are available to prove or refute the
existence of such channels in PMNL.
The activation of phospholipase C pathway leads to generation
of 1P3. The latter mobilizes calcium from intracellular stores.
Such a process would explain the glucose or choline chloride-
induced rise in [Ca2]i of PMNL when they are placed in a
calcium free medium. Also a rise in [Ca2]i by itself may cause
further increase in [Ca2]i by a calcium-induced calcium release
from intracellular stores [61].
Taken together, the results of the present study are consistent
with the formulation that hypertonic media (glucose or choline
chloride) causes shrinkage in cell volume. This is recognized by a
cell membrane sensor (a potential receptor) or cytoskeleton of the
cell that activates a G protein(s), which is followed by: (1)
stimulation of the adenylate cyclase-cAMP-protein kinase A
system with consequent phosphorylation of calcium channels; (2)
activation of the phospholipase C system leading to stimulation of
protein kinase C with consequent activation of calcium channels;
(3) direct activation of calcium channels; and (4) the stimulation
of phospholipase C generates 1P3 that induces calcium release
from intracellular stores. All these pathways and a possible
calcium-induced calcium release from intracellular stores may
contribute to the glucose or choline chloride-induced rise in
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Table 1. Effect of streptozotocin-induccd hyperglycemia for 1, 2 and 12
days on PMNL volume
1 5 10 60 120
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[Ca2 ]i of PMNL. The critical role of the activation of G
protein(s) is supported by our finding that GDPI3S or pertussis
toxin almost complctcly abolished the glucose or the choline
chloride-induced rise in [Ca2]i of PMNL.
Maintenance of cell volume is critical for cell survival. There-
fore, when cells arc exposed to hypotonic or hypertonic surround-
ings, they initiate cellular events to allow them to bring their
volume back to normal [62, 63]. This is done in major part by the
exit of organic osmolytes during cell swelling or the accumulation
of such osmolytes during cell shrinkage [63, 64]. The exact cellular
signals that trigger the loss of osmolytes or their accumulation
during changes in cell volume are not well defined. Activation of
G protein [65] and a rise in [Ca21i [661 have been implicated. Our
data showed that shrinkage of PMNL was associated with activa-
tion of a G protein(s) that leads to the stimulation of a variety of
cellular pathways culminating in a rise in their [Ca2]i. It is
possible that this rise in [Ca2]i is necessary to trigger the
production and accumulation of organic osmolyte that would
bring the volume of PMNL back to normal.
In our study, the volume of the PMNL was reduced within one
minute after their exposure to hypertonic media and remained so
for two hours but became normal after 24 hours. Also PMNL
obtained from rats rendered diabetic with streptozotocin for 1, 2,
and 12 days had normal volume but elevated [Ca2]i. These
observations suggest that the restoration of PMNL volume after
their shrinkage is slow. This is not surprising, since the production
and accumulation of sorbitol, one of th major osmolytes gener-
ated during cell shrinkage, proceeds slowly [63]. Indeed, the
induction of aldose reductase, which stimulates sorhitol produc-
tion, becomes evident six hours after cell shrikage and reaches
maximal activity within two to three days [67]. Therefore, the slow
return of the volume of PMNL to normal observed in our study is
consistent with the notion that accumulation of sorbitol in PMNL
plays an important role in their volume regulation during expo-
sure to hypertonic media. Support for such a role for aldose
reductase is provided by the finding that the activity of this
enzyme in PMNL from patients with type I diabetes is increased
[68]. However, serial measurements of the mRNA and the activity
of aldose reductase as well as sorbitol content of PMNL after their
exposure to a hypertonic medium are needed to confirm this
formulation. If this postulate is substantiated, one may consider
that the elevation in basal levels of [Ca2]i in uncontrolled
diabetes and sustained hyperglycemia is a trade off for the
maintenance of normal cell volume. The observation that the
normalization of blood glucose in diabetes patients (that is,
reduction in the extracellular osmolality) was followed by return
of [Ca2]i of PMNL to normal levels supports this notion [691.
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